NCT06300944 - The Effect of Esketamine on Postoperative Pain Relief in Patients Undergoing Laparoscopic Surgery | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

October 1, 2024

Study Completion Date

December 1, 2024

Conditions

Postoperative Pain

Interventions

DRUG

saline

A maintenance dose of saline is 0.2mg/kg/h and postoperative PCIA regimen was Sufentanil 2ug/kg, ondansetron 16mg, diluted with appropriate normal saline, a total of 100ml

DRUG

Esketamine

A maintenance dose of esketamine is 0.2mg/kg/h and postoperative PCIA regimen was Sufentanil 2ug/kg, ondanseetron 16mg, esketamine 0.75mg/kg, diluted with appropriate normal saline, a total of 100ml

Trial Locations (1)

Unknown

General Hospital of Ningxia Medical University, Yinchuan

All Listed Sponsors

lead

General Hospital of Ningxia Medical University

OTHER